Chamber and committees

12 local authorities have completed their rollout of 20 mph speed limits on appropriate roads with a further 4 due to complete by September. Officials are working closely with the remaining local authorities to support delivery across Scotland.

(a) As noted in our 100-day commitment, we will launch a public consultation on a display ban of vapes and nicotine pouches as part of our on-going implementation of the 2026 Tobacco and Vapes Act (the Act). We also continue to work with the 4-nations on policies concerning restrictions on the packaging and device appearance of vapes using powers in the Act. Decisions on further legislative restrictions on displays, packaging and device appearance of vapes will be dependent on the outcome of consultations. As a result of the Act a free distribution and nominal pricing offence comes into force for vaping products on 29 October 2026 and from 1 June 2027 a comprehensive ban on advertising vapes will come into force.

(b) There are currently no plans to introduce regulations regarding the storage of lithium-ion batteries. However, the storage of lithium-ion batteries, which are used in a range of products, should be informed by a fire risk assessment carried out by a competent fire risk assessor. Fire risk assessments are already a legal requirement for duty holders of all relevant (non-domestic) premises.

Work is currently underway to evaluate the long-term effects of removing peak fares for good and the Scottish Government expects to be able to share initial findings later this year, allowing time to take account of seasonal variations in travel patterns and atypical events such as adverse weather events, impact of the fire incident at Glasgow Union Street or major planned events like the Commonwealth Games.

The removal of ScotRail peak fares for good is currently saving money for hundreds of thousands of people in Scotland, who travel by rail. For example, passengers in the Member’s constituency travelling from Baillieston to Glasgow save £2.60 (36%) and from Shettleston to Glasgow save £2.30 (43%) each time they purchase a return ticket to travel during the busiest commuting times, when compared with previous Anytime Day Return prices.

GP practices are funded to provide cervical screening services as part of their contractual arrangements with NHS boards, and are responsible for ensuring that services are accessible to patients, including those with disabilities.

Practitioners working with physically disabled patients should be confident and experienced in taking cervical samples, and should consider reasonable adjustments based on a patient’s needs. This can include providing longer appointments, using accessible examination equipment, or arranging for screening to take place in alternative settings, such as clinics with hoisting facilities.

NHS Greater Glasgow and Clyde is responsible for ensuring that GP practices and wider services meet these requirements and that appropriate arrangements are in place to support patients requiring additional assistance.

Through Scotland’s Rare Disease Action Plan, we are taking forward actions to improve support for people with Ehlers-Danlos syndromes (EDS) and related conditions, including hypermobility spectrum disorders (HSD). This includes work to support earlier diagnosis, increase awareness among healthcare professionals, and improve coordination of care and access to services. The Rare Disease Action Plan Progress Report, published on 27 February 2026, provides an update on progress to date.

While the Scottish Government sets the strategic policy direction for the NHS in Scotland, the delivery of healthcare services is the responsibility of local NHS Health Boards, in line with national guidance and population needs.

Global events continue to reinforce the impact of high energy prices such as Russia’s illegal full-scale invasion of Ukraine and the crisis in the Middle East. However, other factors are at play such as the UK’s disastrous decision to leave the European Union. This has meant an increase in energy bills.

In an energy-rich nation, no one should struggle to pay their bills.

The Scottish Government continues to support vulnerable households, including those in Glasgow, through our winter heating benefits, with a forecast investment of £205 million in 2026-27. Since 2015, our Warmer Homes Scotland Scheme has invested around £440 million and helped over 51,000 households to live in warmer homes which are more affordable to heat.

We continue to invest in free income maximisation support, welfare and debt advice and have maintained investment in the Scottish Welfare Fund, providing vital support to those in crisis.

It is clear that high energy prices must be addressed. The UK Government must take their responsibility for energy pricing seriously by putting in place robust and effective consumer protections for all fuel users and introducing targeted energy bill discounts to reduce the number of households in fuel poverty.

The following table provides the A83 Rest and Be Thankful maintenance spend per year since 2007. It should be noted that The Scottish Government does not have some of the information you have requested because financial information prior to financial year 2013-14 has not been recorded. This is in accordance with our standard records management practice prior to the date of your request.

Through Scotland’s Rare Disease Action Plan, we are taking forward actions to improve support for people with Ehlers-Danlos syndromes (EDS) and related conditions, including hypermobility spectrum disorders (HSD). This includes work to support earlier diagnosis, increase awareness among healthcare professionals, and improve coordination of care and access to services. The Rare Disease Action Plan Progress Report, published on 27 February 2026, provides an update on progress to date.

While the Scottish Government sets the strategic policy direction for the NHS in Scotland, the delivery of healthcare services is the responsibility of local NHS Health Boards, in line with national guidance and population needs.

Through Scotland’s Rare Disease Action Plan, we are taking forward actions to improve support for people with Ehlers-Danlos syndromes (EDS) and related conditions, including hypermobility spectrum disorders (HSD). This includes work to support earlier diagnosis, increase awareness among healthcare professionals, and improve coordination of care and access to services. The Rare Disease Action Plan Progress Report, published on 27 February 2026, provides an update on progress to date.

While the Scottish Government sets the strategic policy direction for the NHS in Scotland, the delivery of healthcare services is the responsibility of local NHS Health Boards, in line with national guidance and population needs.

There is currently no fully established national clinical pathway for Ehlers–Danlos Syndromes (EDS) or Hypermobility Spectrum Disorders (HSD) specifically commissioned by NHS Scotland.

The development and implementation of clinical pathways is led by NHS under established clinical governance arrangements and informed by clinical evidence and service needs.

Where proposals are put forward for pathway development, these are considered through established, clinically led processes by NHS and relevant national delivery partners.